Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
8.26
-0.31 (-3.62%)
Mar 10, 2025, 3:28 PM EST - Market open
Treace Medical Concepts Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Net Income | -55.74 | -49.53 | -42.82 | -20.55 | -3.67 | Upgrade
|
Depreciation & Amortization | 7.42 | 4.85 | 2.13 | 0.69 | 1.21 | Upgrade
|
Other Amortization | 1.3 | 0.8 | 0.24 | 0.18 | 0.22 | Upgrade
|
Asset Writedown & Restructuring Costs | - | - | 0.35 | - | 0.14 | Upgrade
|
Loss (Gain) From Sale of Investments | -1.15 | -1.41 | -0.13 | - | - | Upgrade
|
Stock-Based Compensation | 30.6 | 17.35 | 8.11 | 3.41 | 0.92 | Upgrade
|
Provision & Write-off of Bad Debts | 2.95 | 0.43 | 0.41 | 0.14 | 0.22 | Upgrade
|
Other Operating Activities | 2.89 | 2.67 | 6.86 | -0.07 | 0.64 | Upgrade
|
Change in Accounts Receivable | -5.69 | -9.3 | -11.04 | -4.23 | -4.29 | Upgrade
|
Change in Inventory | -10.01 | -9.85 | -8.77 | -2.74 | -2.26 | Upgrade
|
Change in Accounts Payable | -1.31 | 3.17 | 4.61 | 1.79 | 1.33 | Upgrade
|
Change in Other Net Operating Assets | -8.42 | 6.24 | 9.39 | 4.19 | 1.04 | Upgrade
|
Operating Cash Flow | -37.17 | -34.58 | -30.65 | -17.19 | -4.49 | Upgrade
|
Capital Expenditures | -11.59 | -11.46 | -14.84 | -2.71 | -1.07 | Upgrade
|
Cash Acquisitions | - | -20 | - | - | - | Upgrade
|
Investment in Securities | 46.97 | -49.84 | -61.68 | - | - | Upgrade
|
Investing Cash Flow | 35.38 | -81.3 | -76.52 | -2.71 | -1.07 | Upgrade
|
Short-Term Debt Issued | - | - | - | - | 1.79 | Upgrade
|
Long-Term Debt Issued | - | - | 53.5 | - | 29.53 | Upgrade
|
Total Debt Issued | - | - | 53.5 | - | 31.32 | Upgrade
|
Short-Term Debt Repaid | - | - | - | -1.79 | - | Upgrade
|
Long-Term Debt Repaid | - | - | -33.89 | - | -20 | Upgrade
|
Total Debt Repaid | - | - | -33.89 | -1.79 | -20 | Upgrade
|
Net Debt Issued (Repaid) | - | - | 19.61 | -1.79 | 11.32 | Upgrade
|
Issuance of Common Stock | 0.43 | 116.9 | 2.19 | 120.04 | 0.36 | Upgrade
|
Repurchase of Common Stock | -0.27 | -0.01 | - | - | - | Upgrade
|
Other Financing Activities | - | -7.5 | -0.99 | -10.6 | -0.18 | Upgrade
|
Financing Cash Flow | 0.16 | 109.38 | 20.81 | 107.65 | 11.5 | Upgrade
|
Net Cash Flow | -1.63 | -6.49 | -86.36 | 87.75 | 5.94 | Upgrade
|
Free Cash Flow | -48.76 | -46.03 | -45.49 | -19.9 | -5.56 | Upgrade
|
Free Cash Flow Margin | -23.29% | -24.60% | -32.07% | -21.07% | -9.70% | Upgrade
|
Free Cash Flow Per Share | -0.79 | -0.76 | -0.82 | -0.41 | -0.15 | Upgrade
|
Cash Interest Paid | 4.96 | 5.17 | 4.4 | 3.9 | 1.15 | Upgrade
|
Levered Free Cash Flow | -30.01 | -33.12 | -37.19 | -12.13 | -3.91 | Upgrade
|
Unlevered Free Cash Flow | -27.02 | -30.18 | -34.69 | -9.77 | -2.4 | Upgrade
|
Change in Net Working Capital | 19.68 | 9.29 | 8.32 | 0.84 | 3.99 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.